Infektionsschutzvorrichtung für Endoexo-Implantate
    7.
    发明公开
    Infektionsschutzvorrichtung für Endoexo-Implantate 有权
    对于endoexo植入物感染控制装置

    公开(公告)号:EP1466566A1

    公开(公告)日:2004-10-13

    申请号:EP04008386.7

    申请日:2004-04-07

    IPC分类号: A61B17/60 A61M1/28 A61F2/78

    摘要: Die Erfindung betrifft eine Infektionsschutzvorrichtung für Endoexo-Implantate 1 gekennzeichnet durch eine schlauchförmige Schutzmembran 2, die aus dem sterilen Bereich des Körperinneren heraus in den unsterilen Außenbereich bewegt wird und so an der Hautdurchtrittsstelle 6 eine Wandbewegung von innen nach außen erzeugt, die das gegenläufige Eindringen von Mikroben verhindert.

    摘要翻译: 本发明涉及一种用于endoexo植入物1的感染控制装置,其特征在于由一个管状保护膜2,这是从内部主体的无菌区移动到未消毒的外部区域,因此产生在皮肤出口部位6从内侧的壁移动到外部,其中,相对的渗透 防止微生物。

    GRAFT-PORT HEMODIALYSIS SYSTEMS, DEVICES AND METHODS
    10.
    发明公开
    GRAFT-PORT HEMODIALYSIS SYSTEMS, DEVICES AND METHODS 审中-公开
    移植血液透析系统,装置和方法

    公开(公告)号:EP3307374A2

    公开(公告)日:2018-04-18

    申请号:EP16808403.6

    申请日:2016-06-10

    申请人: Proviflo, LLC

    IPC分类号: A61M37/00

    摘要: The present invention relates to subcutaneously implanted graft-port systems, devices and methods for establishing access to the vascular system of a patient requiring multiple blood treatments over an extended period of time. The systems, devices and methods disclosed herein reduce miscannulation, promote intra-session hemostasis, and decrease the incidence of bacteremia and sepsis among other improvements and advantages. The devices include a port with a flattened plateau-like surface for receiving an access tube. The flat surface may include a tactile or visual guide to assist with placement of the access tube into the tapered seat. Optional valve mechanisms reduce the size and form factor of the implantable graft-port device and seals the conduit of the port closed to physiologic pressures until the valve is opened upon percutaneous insertion of the access tube. The access tube does not pass into the conduit. A mismatch fit between the access tube and tapered seat causes a decrease in the cross-sectional sealing area, a reduction in the overall device size, and an increase in blood flow during treatment. Lock solutions to prevent fowling and infection are also disclosed.